|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 47/60 | |
| C07K 14/605 | |||
| A61K 38/26 | |||
| C07H 15/04 | |||
| A61P 3/10 |
| (11) | Patento numeris | 2710031 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 12785861.1 |
| Europos patento paraiškos padavimo data | 2012-05-17 | |
| (97) | Europos patento paraiškos paskelbimo data | 2014-03-26 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2017-09-13 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2012/038434 |
| Data | 2012-05-17 |
| (87) | Numeris | WO 2012/158965 |
| Data | 2012-11-22 |
| (30) | Numeris | Data | Šalis |
| 201161487640 P | 2011-05-18 | US | |
| 201161543716 P | 2011-10-05 | US |
| (72) |
NESTOR, John, J., US
|
| (73) |
Mederis Diabetes, LLC,
725 Lynwood Drive, Encinitas, CA 92024,
US
|
| (54) | IMPROVED PEPTIDE PHARMACEUTICALS FOR INSULIN RESISTANCE |
| IMPROVED PEPTIDE PHARMACEUTICALS FOR INSULIN RESISTANCE |